- Home
- ICAD vs APLT Comparison
ICAD vs APLT Comparison
Compare ICAD & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICAD
- APLT
- Stock Information
- Founded
- ICAD 1984
- APLT 2016
- Country
- ICAD United States
- APLT United States
- Employees
- ICAD N/A
- APLT N/A
- Industry
- ICAD Medical/Dental Instruments
- APLT Biotechnology: Pharmaceutical Preparations
- Sector
- ICAD Health Care
- APLT Health Care
- Exchange
- ICAD Nasdaq
- APLT Nasdaq
- Market Cap
- ICAD 87.5M
- APLT 80.3M
- IPO Year
- ICAD 1986
- APLT 2019
- Fundamental
- Price
- ICAD $2.03
- APLT $0.50
- Analyst Decision
- ICAD
- APLT Buy
- Analyst Count
- ICAD 0
- APLT 7
- Target Price
- ICAD N/A
- APLT $6.10
- AVG Volume (30 Days)
- ICAD 270.6K
- APLT 1.6M
- Earning Date
- ICAD 03-19-2025
- APLT 05-08-2025
- Dividend Yield
- ICAD N/A
- APLT N/A
- EPS Growth
- ICAD N/A
- APLT N/A
- EPS
- ICAD N/A
- APLT N/A
- Revenue
- ICAD $19,608,000.00
- APLT N/A
- Revenue This Year
- ICAD $2.39
- APLT N/A
- Revenue Next Year
- ICAD $13.71
- APLT $2,426.33
- P/E Ratio
- ICAD N/A
- APLT N/A
- Revenue Growth
- ICAD 13.22
- APLT N/A
- 52 Week Low
- ICAD $1.18
- APLT $0.43
- 52 Week High
- ICAD $3.78
- APLT $10.62
- Technical
- Relative Strength Index (RSI)
- ICAD 38.33
- APLT 40.46
- Support Level
- ICAD $2.05
- APLT $0.52
- Resistance Level
- ICAD $2.48
- APLT $0.56
- Average True Range (ATR)
- ICAD 0.16
- APLT 0.06
- MACD
- ICAD -0.00
- APLT 0.01
- Stochastic Oscillator
- ICAD 8.33
- APLT 22.65
About ICAD iCAD Inc.
icad Inc is a medical technology company providing cancer detection and therapy solutions. The Company operates in one segment: Detection. The Detection segment include advanced image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies, comprehensive range of high-performance, Artificial Intelligence and Computer-Aided Detection (CAD) systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography. The company geographically operates in France, Belgium, Italy, Germany, Switzerland and All other.
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.